Skip to main content

Advertisement

SpringerLink
Log in

High-dose methylprednisolone for the treatment of sinusoidal obstruction syndrome in adults

  • Correspondence
  • Published:
Bone Marrow Transplantation Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Mohty M, Malard F, Abecassis M, Aerts E, Alaskar AS, Aljurf M, et al. Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation. Bone Marrow Transplant. 2016;51:906–12.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  2. Coppell JA, Richardson PG, Soiffer R, Martin PL, Kernan NA, Chen A, et al. Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome. Biol Blood Marrow Transplant: J Am Soc Blood Marrow Transplant. 2010;16:157–68.

    Article  Google Scholar 

  3. Myers KC, Lawrence J, Marsh RA, Davies SM, Jodele S. High-dose methylprednisolone for veno-occlusive disease of the liver in pediatric hematopoietic stem cell transplantation recipients. Biol Blood Marrow Transplant: J Am Soc Blood Marrow Transplant. 2013;19:500–3.

    Article  CAS  Google Scholar 

  4. Khoury H, Adkins D, Brown R, Trinkaus K, Vij R, Miller G, et al. Does early treatment with high-dose methylprednisolone alter the course of hepatic regimen-related toxicity? Bone Marrow Transplant. 2000;25:737–43.

    Article  PubMed  CAS  Google Scholar 

  5. Richardson PG, Smith AR, Triplett BM, Kernan NA, Grupp SA, Antin JH, et al. Defibrotide for patients with hepatic veno-occlusive disease/sinusoidal obstruction syndrome: interim results from a treatment IND study. Biol Blood Marrow Transplant: J Am Soc Blood Marrow Transplant. 2017;23:997–1004.

    Article  CAS  Google Scholar 

  6. Corbacioglu S, Carreras E, Mohty M, Pagliuca A, Boelens JJ, Damaj G, et al. Defibrotide for the treatment of hepatic veno-occlusive disease: final results from the international compassionate-use program. Biol Blood Marrow Transplant: J Am Soc Blood Marrow Transplant. 2016;22:1874–82.

    Article  CAS  Google Scholar 

  7. Richardson PG, Riches ML, Kernan NA, Brochstein JA, Mineishi S, Termuhlen AM, et al. Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure. Blood. 2016;127:1656–65.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  8. Richardson PG, Soiffer RJ, Antin JH, Uno H, Jin Z, Kurtzberg J, et al. Defibrotide for the treatment of severe hepatic veno-occlusive disease and multiorgan failure after stem cell transplantation: a multicenter, randomized, dose-finding trial. Biol Blood Marrow Transplant: J Am Soc Blood Marrow Transplant. 2010;16:1005–17.

    Article  CAS  Google Scholar 

  9. Hennenfent KL, Augustin KM, Dipersio JF, Khoury H. Is there a role for high-dose methylprednisolone in the treatment of hepatic regimen-related toxicity? Bone Marrow Transplant. 2006;37:229.

    Article  PubMed  CAS  Google Scholar 

  10. Al Beihany A, Al Omar H, Sahovic E, Chaudhri N, Al Mohareb F, Al Sharif F, et al. Successful treatment of hepatic veno-occlusive disease after myeloablative allogeneic hematopoietic stem cell transplantation by early administration of a short course of methylprednisolone. Bone Marrow Transplant. 2008;41:287–91.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Faculty of Medicine, Vilnius University, Vilnius, Lithuania

    Mantas Vaisvilas, Laimonas Griskevicius & Valdas Peceliunas

  2. Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania

    Skirmante Buseckaite, Orinta Mickeviciute, Rita Cekauskiene, Laimonas Griskevicius & Valdas Peceliunas

Authors
  1. Mantas Vaisvilas
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Skirmante Buseckaite
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Orinta Mickeviciute
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Rita Cekauskiene
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Laimonas Griskevicius
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Valdas Peceliunas
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mantas Vaisvilas.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Vaisvilas, M., Buseckaite, S., Mickeviciute, O. et al. High-dose methylprednisolone for the treatment of sinusoidal obstruction syndrome in adults. Bone Marrow Transplant 53, 923–925 (2018). https://doi.org/10.1038/s41409-018-0087-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41409-018-0087-7

  • Springer Nature Limited

Search

Navigation